Miljkovic Milena M,Bielen C,Simic-Koumoutsaris M,Urakpo A (2018) A Review of Benefit-Risk Assessment Over the Product Lifecycle, DRUG SAFETY, vol. 41, br. 11, str. 1169-1169 (Meeting Abstract) 

Miljkovic Milena M,Bielen C,Dobrin D,Kisic Vesna (2017) Challenges of Identifying Safety Signals in Clinical Trials, DRUG SAFETY, vol. 40, br. 10, str. 940-940 (Meeting Abstract) 

Miljkovic Milena M,Dobric Silva Lj,Dragojevic-Simic Viktorija M (2012) Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol. 37, br. 2, str. 196-203 (Article) 

Miljkovic Milena M,Dobric Silva Lj,Dragojevic-Simic Viktorija M (2011) Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 20, br. 3, str. 272-285 (Article) 

Miljkovic Milena M,Djukic Ljiljana L (2000) Analysis of drug utilization in Serbia during the years 1996 and 1997, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 9, br. 1, str. 59-64 (Article)